{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:53:52Z","timestamp":1789707232785,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1716,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/s41374-017-0013-4","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T14:16:39Z","timestamp":1516284999000},"page":"620-628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Disruption of CXCR3 function impedes the development of Sj\u00f6gren's syndrome-like xerostomia in non-obese diabetic mice"],"prefix":"10.1016","volume":"98","author":[{"given":"Jing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41374-017-0013-4_bib1","unstructured":"Jin JO, Yu QT. Cell-associated cytokines in the pathogenesis of Sjogren's syndrome. J Clin Cell Immunol. 2013;S!(9):11742"},{"key":"10.1038\/s41374-017-0013-4_bib2","first-page":"689","article-title":"Sjogren's syndrome","volume":"30","author":"Rhodus","year":"1999","journal-title":"Quintessence Int"},{"key":"10.1038\/s41374-017-0013-4_bib3","first-page":"247","article-title":"The epidemiology of Sjogren's syndrome","volume":"6","author":"Patel","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1038\/s41374-017-0013-4_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1196\/annals.1384.003","article-title":"Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy","volume":"1098","author":"Fox","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1038\/s41374-017-0013-4_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00005-009-0002-4","article-title":"Sjogren's syndrome: an old tale with a new twist","volume":"57","author":"Lee","year":"2009","journal-title":"Arch Immunol Ther Exp"},{"key":"10.1038\/s41374-017-0013-4_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrrheum.2010.118","article-title":"Pathogenetic mechanisms in the initiation and perpetuation of Sjogren's syndrome","volume":"6","author":"Voulgarelis","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1038\/s41374-017-0013-4_bib7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12016-007-8011-8","article-title":"T lymphocytes in Sjogren's syndrome: contributors to and regulators of pathophysiology","volume":"32","author":"Katsifis","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1038\/s41374-017-0013-4_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaut.2012.05.019","article-title":"The T cell in Sjogren's syndrome: force majeure, not spectateur","volume":"39","author":"Singh","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1038\/s41374-017-0013-4_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2567.2007.02614.x","article-title":"B-lymphocyte depletion ameliorates Sjogren's syndrome in Id3 knockout mice","volume":"122","author":"Hayakawa","year":"2007","journal-title":"Immunology"},{"key":"10.1038\/s41374-017-0013-4_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1535-6108(04)00021-2","article-title":"Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis","volume":"5","author":"D'Angelo","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1038\/s41374-017-0013-4_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-3083.2001.00970.x","article-title":"Chemokines and cell trafficking in Sjogren's syndrome","volume":"54","author":"Amft","year":"2001","journal-title":"Scand J Immunol"},{"key":"10.1038\/s41374-017-0013-4_bib12","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","article-title":"CXCR3 in T cell function","volume":"317","author":"Groom","year":"2011","journal-title":"Exp Cell Res"},{"key":"10.1038\/s41374-017-0013-4_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: redundant, collaborative and antagonistic functions","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1038\/s41374-017-0013-4_bib14","first-page":"861","article-title":"Tumor necrosis factor-alpha induces cell type and tissue-specific expression of chemoattractant cytokines in vivo","volume":"142","author":"Ohmori","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1038\/s41374-017-0013-4_bib15","doi-asserted-by":"crossref","first-page":"14899","DOI":"10.1074\/jbc.272.23.14899","article-title":"Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB","volume":"272","author":"Ohmori","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1038\/s41374-017-0013-4_bib16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/labinvest.2016.141","article-title":"Pathogenic role of endogenous TNF-alpha in the development of Sjogren's-like sialadenitis and secretory dysfunction in non-obese diabetic mice","volume":"97","author":"Zhou","year":"2017","journal-title":"Lab Invest"},{"key":"10.1038\/s41374-017-0013-4_bib17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1749-6632.2009.04813.x","article-title":"CXCR3, inflammation, and autoimmune diseases","volume":"1173","author":"Lacotte","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1038\/s41374-017-0013-4_bib18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S","article-title":"Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation","volume":"194","author":"Flier","year":"2001","journal-title":"J Pathol"},{"key":"10.1038\/s41374-017-0013-4_bib19","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI5150","article-title":"Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients","volume":"103","author":"Sorensen","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1038\/s41374-017-0013-4_bib20","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/ibd.21312","article-title":"Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease","volume":"16","author":"Schroepf","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1038\/s41374-017-0013-4_bib21","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/1529-0131(200105)44:5<1022::AID-ANR181>3.0.CO;2-N","article-title":"Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes\/macrophages in rheumatoid arthritis","volume":"44","author":"Katschke","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1038\/s41374-017-0013-4_bib22","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/nm1202-792","article-title":"Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis","volume":"8","author":"Frigerio","year":"2002","journal-title":"Nat Med"},{"key":"10.1038\/s41374-017-0013-4_bib23","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1681\/ASN.2007111179","article-title":"CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease","volume":"19","author":"Menke","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/s41374-017-0013-4_bib24","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.4049\/jimmunol.0802626","article-title":"CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis","volume":"183","author":"Steinmetz","year":"2009","journal-title":"J Immunol"},{"key":"10.1038\/s41374-017-0013-4_bib25","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1073\/pnas.1118104109","article-title":"Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation","volume":"109","author":"O'Boyle","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/s41374-017-0013-4_bib26","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.4049\/jimmunol.1501798","article-title":"CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata","volume":"197","author":"Dai","year":"2016","journal-title":"J Immunol"},{"key":"10.1038\/s41374-017-0013-4_bib27","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.4049\/jimmunol.179.12.8463","article-title":"Blockade of chemokine receptor CXCR3 inhibits T cell recruitment to inflamed joints and decreases the severity of adjuvant arthritis","volume":"179","author":"Mohan","year":"2007","journal-title":"J Immunol"},{"key":"10.1038\/s41374-017-0013-4_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/cc11642","article-title":"Therapeutic efficacy of CXCR3 blockade in an experimental model of severe sepsis","volume":"16","author":"Herzig","year":"2012","journal-title":"Crit Care"},{"key":"10.1038\/s41374-017-0013-4_bib29","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/art.34330","article-title":"A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis","volume":"64","author":"Yellin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1038\/s41374-017-0013-4_bib30","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/art.11128","article-title":"Expression of the interferon-gamma-inducible 10-kd protein and CXC receptor 3 in the salivary gland lesions of patients with Sjogren's syndrome: comment on the article by Ogawa et al","volume":"48","author":"Sfriso","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1038\/s41374-017-0013-4_bib31","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1002\/art.10577","article-title":"Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjogren's syndrome","volume":"46","author":"Ogawa","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1038\/s41374-017-0013-4_bib32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.clim.2004.03.008","article-title":"Expression of interferon-inducible T cell alpha chemoattractant (CXCL11) in the salivary glands of patients with Sjogren's syndrome","volume":"112","author":"Ogawa","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1038\/s41374-017-0013-4_bib33","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/art.21745","article-title":"Antagonist of interferon-inducible protein 10\/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL\/lpr mice","volume":"54","author":"Hasegawa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1038\/s41374-017-0013-4_bib34","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1073\/pnas.0801544105","article-title":"Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria","volume":"105","author":"Campanella","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/s41374-017-0013-4_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/TP.0b013e31817b8e4b","article-title":"Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody","volume":"86","author":"Uppaluri","year":"2008","journal-title":"Transplantation"},{"key":"10.1038\/s41374-017-0013-4_bib36","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/art.27564","article-title":"Significance of B cells and B cell clonality in Sjogren's syndrome","volume":"62","author":"Youinou","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1038\/s41374-017-0013-4_bib37","first-page":"970","article-title":"Salivary cytokine profiles in primary Sjogren's syndrome differ from those in non-Sjogren sicca in terms of TNF-alpha levels and Th-1\/Th-2 ratios","volume":"29","author":"Kang","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1038\/s41374-017-0013-4_bib38","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.4049\/jimmunol.152.11.5532","article-title":"Cytokine mRNA expression in salivary gland biopsies of Sjogren's syndrome","volume":"152","author":"Fox","year":"1994","journal-title":"J Immunol"},{"key":"10.1038\/s41374-017-0013-4_bib39","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/art.27362","article-title":"Disruption of tight junction structure in salivary glands from Sjogren's syndrome patients is linked to proinflammatory cytokine exposure","volume":"62","author":"Ewert","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1038\/s41374-017-0013-4_bib40","doi-asserted-by":"crossref","first-page":"C1191","DOI":"10.1152\/ajpcell.00144.2008","article-title":"Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma alter tight junction structure and function in the rat parotid gland Par-C10 cell line","volume":"295","author":"Baker","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1038\/s41374-017-0013-4_bib41","doi-asserted-by":"crossref","first-page":"278948","DOI":"10.1155\/2010\/278948","article-title":"Tight junctions in salivary epithelium","volume":"2010","author":"Baker","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1038\/s41374-017-0013-4_bib42","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1073\/pnas.1601992113","article-title":"Aquaporin gene therapy corrects Sjogren's syndrome phenotype in mice","volume":"113","author":"Lai","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/s41374-017-0013-4_bib43","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1159\/000088179","article-title":"A mouse caries model and evaluation of aqp5-\/- knockout mice","volume":"39","author":"Culp","year":"2005","journal-title":"Caries Res"},{"key":"10.1038\/s41374-017-0013-4_bib44","doi-asserted-by":"crossref","first-page":"20071","DOI":"10.1074\/jbc.274.29.20071","article-title":"Defective secretion of saliva in transgenic mice lacking aquaporin-5 water channels","volume":"274","author":"Ma","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1038\/s41374-017-0013-4_bib45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaut.2013.12.012","article-title":"The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjogren's syndrome: a critical review","volume":"51","author":"Sumida","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1038\/s41374-017-0013-4_bib46","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1172\/JCI78578","article-title":"CXCR3 blockade protects against Listeria monocytogenes infection-induced fetal wastage","volume":"125","author":"Chaturvedi","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1038\/s41374-017-0013-4_bib47","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.4049\/jimmunol.1001049","article-title":"Inhibiting CXCR3-dependent CD8 + T cell trafficking enhances tolerance induction in a mouse model of lung rejection","volume":"186","author":"Seung","year":"2011","journal-title":"J Immunol"},{"key":"10.1038\/s41374-017-0013-4_bib48","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/ar2341","article-title":"The role of tumor necrosis factor-alpha in systemic lupus erythematosus","volume":"10","author":"Aringer","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1038\/s41374-017-0013-4_bib49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1874312901206010315","article-title":"Anti-tumor necrosis factor-alpha induced systemic lupus erythematosus","volume":"6","author":"Almoallim","year":"2012","journal-title":"Open Rheumatol J"},{"key":"10.1038\/s41374-017-0013-4_bib50","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.22327","article-title":"Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus","volume":"56","author":"Aringer","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1038\/s41374-017-0013-4_bib51","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1002\/art.20576","article-title":"Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study","volume":"50","author":"Aringer","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1038\/s41374-017-0013-4_bib52","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","article-title":"Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases","volume":"13","author":"Antonelli","year":"2014","journal-title":"Autoimmun Rev"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41374-017-0013-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41374-017-0013-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722011163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722011163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41374-017-0013-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:35:24Z","timestamp":1758396924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722011163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0023683722011163"],"URL":"https:\/\/doi.org\/10.1038\/s41374-017-0013-4","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disruption of CXCR3 function impedes the development of Sj\u00f6gren's syndrome-like xerostomia in non-obese diabetic mice","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41374-017-0013-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}